Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A
Laura Breen, Patricia Gaule, Alexandra Canonici, Naomi Walsh, Denis M. Collins, Mattia Cremona, Bryan T. Hennessy, Michael J. Duffy, John Crown, N. O' Donovan, Alex J. Eustace
Topics & Concepts
NeratinibTriple-negative breast cancerCancer researchBreast cancerMedicineCancerHepatocyte growth factorOncologyInternal medicineTrastuzumabReceptorCancer Cells and MetastasisLiver physiology and pathologyHER2/EGFR in Cancer Research